Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibacterial therapy: problems and promises, Part II.

H C Neu1

  • 1Columbia University College of Physicians and Surgeons, New York.

Hospital Practice (Office Ed.)
|June 15, 1990
PubMed
Summary

New antibacterial drugs like quinolones and macrolides offer improved activity against resistant bacteria. These advanced antibiotics reduce toxicity and dosing frequency, with many available orally to shorten hospital stays.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postantibiotic effect of ceftibuten on respiratory pathogens.

The Pediatric infectious disease journal·1995
Same author

Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.

The Pediatric infectious disease journal·1995
Same author

In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.

Antimicrobial agents and chemotherapy·1994
Same author

Emerging trends in antimicrobial resistance in surgical infections. A review.

The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·1994
Same author

Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents.

Drugs·1993
Same author

Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages.

The Journal of experimental medicine·1992

Area of Science:

  • Pharmacology and Infectious Diseases

Background:

  • The emergence of antibiotic resistance poses a significant threat to public health.
  • There is a continuous need for novel antibacterial agents to combat challenging infections.

Purpose of the Study:

  • To review recently approved and upcoming antibacterial agents.
  • To highlight advancements in antibacterial drug development.

Main Methods:

  • Literature review of new antibacterial drug classes.
  • Analysis of pharmacological properties and clinical applications.

Main Results:

  • New quinolones, macrolides, aminoglycosides, glycopeptides, and lipopeptides are discussed.
  • These agents demonstrate enhanced activity against resistant pathogens.
  • Improved safety profiles and reduced administration frequency are noted.

Conclusions:

  • The reviewed antibacterial agents represent significant progress in combating resistant infections.
  • Oral administration and reduced treatment burden are key benefits, potentially shortening hospital stays.

Related Experiment Videos